"Remember, cancer never sleeps...Failure is NOT an option.
This is the United States of America."
This July 4th declare independence from your work week and celebrate the holiday with family and friends. We've got a great month planned, featuring Childhood Cancer Awareness,YoungAdult Cancer Awareness and much more! Already have plans? Join US and make a difference for your family and friends.
"Remember, cancer never sleeps...Failure is NOT an option. This is the United States of America."
With these empowering words, Vice President Joe Biden convened Wednesday's inaugural Cancer Moonshot Summit in Washington, D.C.
The summit comes just 13 months after the loss of Biden's son, Beau, to cancer, and marks an integral first step in achieving the Vice President's $1 Billion "Cancer Moonshot" goal to make "a decade's-worth of difference in five years" toward curing cancer. CONNECT4CANCER was well represented around the country at Summit locations. We raised our voice to be heard on behalf of all our C4C members. More to follow...
JULY is SARCOMA AWARENESS MONTH. In 2016, 4,990 Americans are expected to die of soft tissue sarcoma. 2,680 males and 2,310 females. This year there will be 12,310 new soft tissue sarcoma cancer patients diagnosed.
C4C have many friends who have battled sarcoma cancer. It is a terrible. Our friend Ashley Capp's dad has sarcoma and we wish him well. Our C4C executive committee member, Stephanie, had Ewing's Sarcoma. Riley Kim (13) has Epithelioid Sarcoma. Our friend, Maria, has survived sarcoma. Kevin Evans has rhabdomyosarcoma. God Bless them all.
C4C STUDENT ADVOCATES
We are excited to announce that the Connect4Cancer Student Advocates Program is ready to go. Thank you to all members of Congress who have made this possible. This year, for the first time we will also be visiting the Senate office buildings and chambers. Topics include the latest in childhood cancer research, legislation, ramifications of Vice President Joe Biden's Cancer Moonshot program and "How to be an ACTIVIST" for Cancer Issues.